第十四届中国创新创业大赛山东赛区，山东铂锐激光科技有限公司的高端短脉冲激光器产业化项目拿到 了第三名的好成绩，公司负责人叶帅难掩喜悦之情，不久前，他还在为更新设备的资金缺口发愁，正是 市财政局、市人社局等部门联合推出的"济担-创业贷"帮他解决了创业路上的资金难题。 订单增长引发的资金困局 在济南，山东铂锐激光科技有限公司凭借着过硬的技术实力，在高端激光器研发领域大放异彩。作为国 内少有的同时精通光纤和固体激光技术的创新型企业，其研发的皮秒、飞秒激光器填补了国内多项技术 空白，为我国激光技术发展贡献了关键力量。但就在不久前，这家科技新锐企业险些因资金问题发展受 阻。 高端激光器研发过程不仅需要持续投入大量资金，周期也十分漫长，随着铂锐激光业务不断拓展，订单 量显著增长，资金流动性压力也随之剧增。叶帅回忆道："高端激光器研发就像在'无人区'探险，前期 投入大、周期长，原材料采购、设备升级都需要钱，订单来了反而更愁。传统贷款通常要求房产抵押， 对于我们这种以技术和设备为主的轻资产科技企业而言，很难满足抵押要求。研发投入受限、设备更新 计划搁置、订单交付压力增大，资金难题让我们陷入了僵局。" ▲铂锐激光生产车间 政策 ...

Core Viewpoint - The beauty and cosmetic surgery market in China is rapidly expanding, with an estimated market size of nearly 300 billion yuan in 2024 [1]. Regulatory Developments - The National Healthcare Security Administration (NHSA) has issued a guideline to standardize pricing for commonly used cosmetic surgery services, addressing the prevalent issue of price discrepancies in the booming market [2][4]. - The guideline does not alter the market-based pricing management but aims to unify project names and standardize pricing behaviors among medical institutions [4]. Pricing Structure - Medical institutions can set their own prices for cosmetic surgery services, leading to significant price variations. The new guideline categorizes established procedures under unified names and standardizes abstract pricing projects [4][6]. - The guideline allows for the inclusion of popular treatments under specific categories, such as "ultrasound treatment" and "radiofrequency treatment," to enhance clarity in pricing [6]. Customization and Innovation - The guideline reflects the diverse and personalized needs of patients, allowing for detailed categorization of common procedures, such as lip enhancement [8]. - Medical institutions are permitted to establish additional charges for new technologies and equipment, subject to local healthcare department approval [8]. New Pricing Projects - The guideline introduces new pricing projects for "reduction of scarring through cosmetic suturing" and "surgical incision beautification," encouraging medical professionals to minimize scarring from the outset [9][11]. - A new charge for "revision surgery" has been established, recognizing the increased complexity and difficulty of follow-up procedures compared to initial surgeries [12][14].

南京波长光电科技股份有限公司 首次公开发行股票并在创业板上市发行公告 保荐人（主承销商）：华泰联合证券有限责任公司 特别提示 根据《国民经济行业分类》（GB/T 4754-2017），南京波长光电科技股份有限 公司（以下简称"波长光电"、"发行人"或"公司"）所属行业为"仪器仪表制造业 （C40）"，细分行业为"光学仪器制造（C4040）"。截至 2023 年 8 月 8 日(T-4 日)， 中证指数有限公司发布的"C40 仪器仪表制造业"最近一个月平均静态市盈率为 39.05 倍。本次发行价格 29.38 元/股对应的发行人 2022 年扣除非经常性损益前 后孰低的摊薄后市盈率为 60.67 倍，高于可比公司 2022 年扣非后平均静态市盈 率，超出幅度为 18.13%；高于中证指数有限公司发布的行业最近一个月平均静 态市盈率，超出幅度为 55.37%，可能存在未来发行人股价下跌给投资者带来损 失的风险。发行人和保荐人（主承销商）提请投资者关注投资风险，审慎研判发 行定价的合理性，理性作出投资。 波长光电根据中国证券监督管理委员会（以下简称"中国证监会"）颁布的 《证券发行与承销管理办法》（证监会令[第 2 ...